KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Non-Current Debt: 2009-2025

Historic Non-Current Debt for Teva Pharmaceutical Industries (TEVA) over the last 17 years, with Sep 2025 value amounting to $16.8 billion.

  • Teva Pharmaceutical Industries' Non-Current Debt rose 2.23% to $16.8 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $16.8 billion, marking a year-over-year increase of 2.23%. This contributed to the annual value of $16.0 billion for FY2024, which is 11.89% down from last year.
  • Teva Pharmaceutical Industries' Non-Current Debt amounted to $16.8 billion in Q3 2025, which was up 0.02% from $16.8 billion recorded in Q2 2025.
  • In the past 5 years, Teva Pharmaceutical Industries' Non-Current Debt registered a high of $22.3 billion during Q1 2021, and its lowest value of $16.0 billion during Q4 2024.
  • Over the past 3 years, Teva Pharmaceutical Industries' median Non-Current Debt value was $16.8 billion (recorded in 2025), while the average stood at $17.3 billion.
  • Its Non-Current Debt has fluctuated over the past 5 years, first declined by 15.68% in 2024, then grew by 2.23% in 2025.
  • Over the past 5 years, Teva Pharmaceutical Industries' Non-Current Debt (Quarterly) stood at $21.6 billion in 2021, then decreased by 11.63% to $19.1 billion in 2022, then declined by 4.93% to $18.2 billion in 2023, then declined by 11.89% to $16.0 billion in 2024, then climbed by 2.23% to $16.8 billion in 2025.
  • Its Non-Current Debt stands at $16.8 billion for Q3 2025, versus $16.8 billion for Q2 2025 and $16.2 billion for Q1 2025.